United States:
FDA Announced That The Following Collections Have Been Submitted To OMB - April 2015
To print this article, all you need is to be registered or login on Mondaq.com.
-
Evaluation of the Food and Drug Administration's "Fresh
Empire" Multicultural Youth Tobacco Prevention Campaign
-
Waiver of In Vivo Demonstration of Bioequivalence of Animal
Drugs in Soluble Powder Oral Dosage Form Products and Type A
Medicated Articles
-
Prominent and Conspicuous Mark of Manufacturers on Single-Use
Devices
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
Healthcare Policy Developments To Watch In 2024
Crowell & Moring LLP
The ever-changing healthcare policy landscape will witness at the federal level regulatory changes driven by the need to transform healthcare delivery, quality and innovation.
The FDA And The Future Of AI Oversight
Manatt, Phelps & Phillips LLP
In January 2024, the U.S. Government Accountability Office (GAO) issued a report highlighting current obstacles to the U.S. Food and Drug Administration's (FDA) timely and effective regulation...